Sr Epidemiologist at IQVIA

Paris, Île-de-France, France

IQVIA Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, PharmaceuticalsIndustries

Requirements

  • Diplôme de niveau Master ou PhD en épidémiologie, pharmacoépidémiologie, santé publique ou domaine scientifique connexe
  • Expérience confirmée dans la conception et la réalisation d’études en vie réelle
  • Connaissance de l’environnement SNDS indispensable
  • Excellentes compétences rédactionnelles et communicationnelles
  • Maîtrise des outils bureautiques (Word, Excel, PowerPoint) et des logiciels statistiques (SAS et/ou R)
  • Capacité à interpréter des résultats issus de SAS, R ou autres langages statistiques
  • Sens de l’organisation, autonomie et esprit d’équipe
  • Anglais professionnel requis

Responsibilities

  • Concevoir et piloter des études observationnelles en épidémiologie et pharmacoépidémiologie
  • Rédiger des protocoles, rapports et documents d’étude avec rigueur scientifique
  • Fournir un soutien méthodologique sur les plans d’analyse statistique
  • Interagir avec les clients et les parties prenantes pour garantir la qualité des livrables
  • Participer à l’amélioration continue des processus internes et aux initiatives de développement commercial

Skills

Epidemiology
Pharmacoepidemiology
Observational Studies
Real World Evidence
Statistical Analysis
Protocol Development
Report Writing
Public Health

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters
1998Year Founded
$3,526MTotal Funding
POST_IPO_EQUITYCompany Stage
Cybersecurity, Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.
Proliferation of disparate technological solutions causes technology overload in clinical trials.
Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.
The company offers privacy-enhancing technologies to protect individual patient data.
IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.
AI-driven drug discovery accelerates identification of potential drug candidates.
Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI